LACEY, J.; HEWITT, J.; DALEY-MORRIS, J. L.; JAMES, J.; STEVENS, J.; BLAIZEL, O. Expert clinical framework report: Management of adverse events related to novel therapies for relapsed/refractory multiple myeloma (RRMM). Canadian Hematology Today, Toronto, Canada, v. 1, n. S11, 2022. DOI: 10.58931/cht.2022.1S1130. Disponível em: https://canadianhematologytoday.com/article/view/30. Acesso em: 9 may. 2024.